Cover Image
Market Research Report
Product code
883718

Asia-Pacific PCR Multiplex Assays Market - Industry Trends & Forecast to 2026

Published: | Data Bridge Market Research Private Limited | 350 Pages | Delivery time: 3-5 business days

Price

Back to Top
Asia-Pacific PCR Multiplex Assays Market - Industry Trends & Forecast to 2026
Published: June 1, 2019
Data Bridge Market Research Private Limited
Content info: 350 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

Asia-Pacific PCR multiplex assays market is projected to register a substantial CAGR in the forecast period 2019 to 2026. The new market report contains data for the historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines, New Zealand, Vietnam, Rest of Asia-Pacific)

Some of the major factors contributing to the growth of the Asia-Pacific market:

  • Improving healthcare infrastructure
  • Increasing R&D expenditure in health care industry.
  • Increasing cases of diseases and use in diagnostic purpose

Market Players:

The key market players for Asia-Pacific PCR multiplex assays market are listed below:

  • Thermo Fisher Scientific Inc.
  • Luminex Corporation
  • BD
  • QIAGEN
  • Agilent Technologies Inc.
  • Meso Scale Diagnostics, LLC
  • Randox Laboratories Ltd.
  • Bio-Techne, Seegene Inc.
  • Olink
  • Illumina, Inc
  • Bio-Rad Laboratories, Inc
  • Abcam Plc
  • Quanterix
  • Sysmex Corporation
  • Siemens
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Diasorin
  • Abbott
  • Quest Diagnostics Incorporated
  • PerkinElmer Inc
  • Eurofins Scientific
  • Agena Bioscience, Inc.
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 MARKET APPLICATION COVERAGE GRID
  • 2.9 DBMR VENDOR SHARE ANALYSIS
  • 2.10 MULTIVARIATE MODELING
  • 2.11 PRODUCTS LIFELINE CURVE
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 TECHNOLOGICAL ADVANCEMENTS OF PCR MULTIPLEX ASSAYS
    • 3.1.2 INTRODUCTION OF NOVEL AUTOMATED SYSTEMS
    • 3.1.3 GROWING RESEARCH AND DEVELOPMENT FOR DRUG DISCOVERY
    • 3.1.4 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
  • 3.2 RESTRAINTS
    • 3.2.1 HIGH COST OF THE MULTIPLEX ASSAYS
    • 3.2.2 STRINGENT REGULATIONS AND STANDARDS
  • 3.3 OPPORTUNITIES
    • 3.3.1 GROWING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
    • 3.3.2 BUSINESS EXPANSION FOR DEVELOPMENT OF PCR MULTIPLEX ASSAYS
  • 3.4 CHALLENGE
    • 3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES

  • 6.1 OVERVIEW
  • 6.2 REAGENTS & CONSUMABLES
  • 6.3 INSTRUMENTS & ACCESSORIES
  • 6.4 SOFTWARE AND SERVICES

7 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 7.1 OVERVIEW
  • 7.2 CLINICAL DIAGNOSTICS
    • 7.2.1 CANCER
    • 7.2.2 CARDIOVASCULAR DISEASES
    • 7.2.3 RESPIRATORY DISEASES
    • 7.2.4 METABOLISM & ENDOCRINOLOGY DISORDERS
    • 7.2.5 NERVOUS SYSTEM DISORDERS
    • 7.2.6 AUTOIMMUNE DISEASES
    • 7.2.7 ALLERGIES
    • 7.2.8 OTHERS
  • 7.3 RESEARCH & DEVELOPMENT
    • 7.3.1 DRUG DISCOVERY & DEVELOPMENT
    • 7.3.2 BIOMARKER DISCOVERY & VALIDATION

8 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 CLINICAL LABORATORIES
  • 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.5 RESEARCH INSTITUTES
  • 8.6 OTHERS

9 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY

  • 9.1 ASIA-PACIFIC
    • 9.1.1 CHINA
    • 9.1.2 JAPAN
    • 9.1.3 INDIA
    • 9.1.4 AUSTRALIA
    • 9.1.5 SOUTH KOREA
    • 9.1.6 SINGAPORE
    • 9.1.7 MALAYSIA
    • 9.1.8 INDONESIA
    • 9.1.9 THAILAND
    • 9.1.10 PHILIPPINES
    • 9.1.11 REST OF ASIA-PACIFIC

10 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 SWOT ANALYSIS

  • 11.1 STRENGTH: - SIGNIFICANT INCREASING SHARES IN MARKET FOCUSED SEGMENT
  • 11.2 STRENGTH: - STRONG ASIA-PACIFIC PRESENCE AND MARKET SHARE
  • 11.3 WEAKNESS: - PRODUCT RECALL
  • 11.4 OPPORTUNITY: - STRATEGIC INVESTMENTS
  • 11.5 THREAT: - STIFF COMPETITION

12 COMPANY PROFILES

  • 12.1 F. HOFFMANN-LA ROCHE LTD.
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 REVENUE ANALYSIS
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 HOL0GIC INC
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENTS
  • 12.3 LUMINEX CORPORATION.
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENTS

  • 12.4 BECTON, DICKINSON AND COMPANY
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 REVENUE ANALYSIS
    • 12.4.3 COMPANY SHARE ANALYSIS
    • 12.4.4 PRODUCT PORTFOLIO
    • 12.4.5 RECENT DEVELOPMENTS
  • 12.5 ABBOTT
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 REVENUE ANALYSIS
    • 12.5.3 PRODUCT PORTFOLIO
    • 12.5.4 RECENT DEVELOPMENTS
  • 12.6 AGENA BIOSCIENCE, INC
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 PRODUCT PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENT
  • 12.7 AGILENT TECHNOLOGIES, INC
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 REVENUE ANALYSIS
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENT
  • 12.8 BIO-RAD LABORATORIES, INC.
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 REVENUE ANALYSIS
    • 12.8.3 PRODUCT PORTFOLIO
    • 12.8.4 RECENT DEVELOPMENTS
  • 12.9 BIOMERIEUX SA
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 REVENUE ANALYSIS
    • 12.9.3 PRODUCT PORTFOLIO
    • 12.9.4 RECENT DEVELOPMENTS
  • 12.10 BIOTEK INSTRUMENTS, INC.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 PRODUCT PORTFOLIO
    • 12.10.3 RECENT DEVELOPMENT
  • 12.11 DIASORIN S.P.A
    • 12.11.1 COMPANY SNAPSHOT
    • 12.11.2 REVENUE ANALYSIS
    • 12.11.3 PRODUCT PORTFOLIO
    • 12.11.4 RECENT DEVELOPMENT

  • 12.12 EUROFINS SCIENTIFIC
    • 12.12.1 COMPANY SNAPSHOT
    • 12.12.2 REVENUE ANALYSIS
    • 12.12.3 PRODUCT PORTFOLIO
    • 12.12.4 RECENT DEVELOPMENT
  • 12.13 ILLUMINA, INC.
    • 12.13.1 COMPANY SNAPSHOT
    • 12.13.2 REVENUE ANALYSIS
    • 12.13.3 PRODUCT PORTFOLIO
    • 12.13.4 RECENT DEVELOPMENT
  • 12.14 OLINK
    • 12.14.1 COMPANY SNAPSHOT
    • 12.14.2 PRODUCT PORTFOLIO
    • 12.14.3 RECENT DEVELOPMENT
  • 12.15 PATHONOSTICS B.V.
    • 12.15.1 COMPANY SNAPSHOT
    • 12.15.2 PRODUCT PORTFOLIO
    • 12.15.3 RECENT DEVELOPMENT
  • 12.16 PERKINELMER INC.
    • 12.16.1 COMPANY SNAPSHOT
    • 12.16.2 REVENUE ANALYSIS
    • 12.16.3 PRODUCT PORTFOLIO
    • 12.16.4 RECENT DEVELOPMENT
  • 12.17 QIAGEN
    • 12.17.1 COMPANY SNAPSHOT
    • 12.17.2 REVENUE ANALYSIS
    • 12.17.3 PRODUCT PORTFOLIO
    • 12.17.4 RECENT DEVELOPMENTS
  • 12.18 QUEST DIAGNOSTICS INCORPORATED
    • 12.18.1 COMPANY SNAPSHOT
    • 12.18.2 REVENUE ANALYSIS
    • 12.18.3 PRODUCT PORTFOLIO
    • 12.18.4 RECENT DEVELOPMENT
  • 12.19 RANDOX LABORATORIES LTD.
    • 12.19.1 COMPANY SNAPSHOT
    • 12.19.2 PRODUCT PORTFOLIO
    • 12.19.3 RECENT DEVELOPMENT

  • 12.20 SEEGENE INC.
    • 12.20.1 COMPANY SNAPSHOT
    • 12.20.2 REVENUE ANALYSIS
    • 12.20.3 PRODUCT PORTFOLIO
    • 12.20.4 RECENT DEVELOPMENT
  • 12.21 SIEMENS
    • 12.21.1 COMPANY SNAPSHOT
    • 12.21.2 REVENUE ANALYSIS
    • 12.21.3 PRODUCT PORTFOLIO
    • 12.21.4 RECENT DEVELOPMENTS
  • 12.22 SYSMEX CORPORATION
    • 12.22.1 COMPANY SNAPSHOT
    • 12.22.2 REVENUE ANALYSIS
    • 12.22.3 PRODUCT PORTFOLIO
    • 12.22.4 RECENT DEVELOPMENTS
  • 12.23 THERMO FISHER SCIENTIFIC INC.
    • 12.23.1 COMPANY SNAPSHOT
    • 12.23.2 REVENUE ANALYSIS
    • 12.23.3 PRODUCT PORTFOLIO
    • 12.23.4 RECENT DEVELOPMENT

13 CONCLUSION

14 QUESTIONNAIRE

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 RESEARCH AND DEVELOPMENT ACTIVITIES OF MAJOR BIO-PHARMA COMPANIES
  • TABLE 2 LIST OF HUMAN GENETIC TESTS
  • TABLE 3 THE COST OF THE FEW REAGENT USED IN THE PCR MULTIPLEX ASSAYS ARE;
  • TABLE 4 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 5 ASIA-PACIFIC REAGENTS & CONSUMABLES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 ASIA-PACIFIC INSTRUMENTS & ACCESSORIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 ASIA-PACIFIC SOFTWARE AND SERVICES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 9 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 11 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 ASIA-PACIFIC RESEARCH & DEVELOPMENT IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 13 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 14 ASIA-PACIFIC HOSPITALS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 ASIA-PACIFIC CLINICAL LABORATORIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 ASIA-PACIFIC RESEARCH INSTITUTES IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 ASIA-PACIFIC OTHERS IN PCR MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 20 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 21 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 ASIA-PACIFIC CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 23 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 25 CHINA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 26 CHINA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 27 CHINA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 28 CHINA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 29 CHINA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 30 JAPAN PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 31 JAPAN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 32 JAPAN CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 33 JAPAN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 34 JAPAN PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 35 INDIA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 36 INDIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 37 INDIA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 38 INDIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 39 INDIA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 40 AUSTRALIA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 41 AUSTRALIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 42 AUSTRALIA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 AUSTRALIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 44 AUSTRALIA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 45 SOUTH KOREA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 46 SOUTH KOREA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 47 SOUTH KOREA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 48 SOUTH KOREA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 49 SOUTH KOREA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 50 SINGAPORE PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 51 SINGAPORE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 SINGAPORE CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 53 SINGAPORE PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 54 SINGAPORE PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 55 MALAYSIA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 56 MALAYSIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 57 MALAYSIA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 58 MALAYSIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 59 MALAYSIA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 60 INDONESIA PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 61 INDONESIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 62 INDONESIA CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 63 INDONESIA PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 64 INDONESIA PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 65 THAILAND PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 66 THAILAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 67 THAILAND CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 68 THAILAND PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 69 THAILAND PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 70 PHILIPPINES PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 71 PHILIPPINES PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 72 PHILIPPINES CLINICAL DIAGNOSTICS IN PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 73 PHILIPPINES PCR MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 74 PHILIPPINES PCR MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 75 REST OF ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: SEGMENTATION
  • FIGURE 2 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: ASIA-PACIFIC VS REGIONAL ANALYSIS
  • FIGURE 5 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET
  • FIGURE 11 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: SEGMENTATION
  • FIGURE 12 TECHNOLOGICAL ADVANCEMENTS OF ASIA-PACIFIC PCR MULTIPLEX ASSAYS AND INTRODUCTION OF NOVEL AUTOMATED SYSTEMS ARE EXPECTED TO DRIVE THE ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 13 REAGENTS & CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET IN 2019 & 2026
  • FIGURE 14 ASIA-PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES, 2018
  • FIGURE 16 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 17 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET : BY END USER, 2018
  • FIGURE 18 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: SNAPSHOT (2018)
  • FIGURE 19 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018)
  • FIGURE 20 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 21 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 22 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES(2019-2026)
  • FIGURE 23 ASIA-PACIFIC PCR MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%)